We’re proud to celebrate a major milestone: over 1,000 corneal treatments successfully performed using theranostics technology with the C4V CHROMO4VIS and RitSight medical devices!
These treatments, targeting keratoconus and other corneal pathologies, mark a new era in ophthalmology where precision, personalization, and predictability are at the core of care. Thanks to real-time molecular monitoring, physicians are empowered to optimize outcomes and ensure safety at every treatment step.
This achievement reflects the trust of a growing network of leading corneal surgeons and clinics across EU and MENA, who are pioneering this innovation with us.